Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.42972 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.62989 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.22285 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.3689 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36918 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.46242 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.44903 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.40329 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.38972 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.41172 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.41316 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.39367 | 17 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43774 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.42028 | 18 |